Log in

Suraksha Diagnostic

NSE: SURAKSHA · ISIN INE877V01027 · Healthcare

₹353.85+10.20 (+2.97%)

Monday 9 November, 12:05 IST. Delayed. Source: Yahoo Finance.

Price chart

₹353.85 +10.20 (+2.97%) today

The day

Previous close
₹343.65
Open
₹343.00
Day high
₹359.50
Day low
₹341.55

Listed on NSE since 6 December 2024.

Key numbers

Market value
₹1,789.76 Cr
P/E (trailing)
49.95
EPS (trailing)
₹6.88
Price to book
7.28
Dividend yield
0.15%
Debt to equity
0.54
Profit margin
11.0%
Volume today
1.01 L
Average volume
1.70 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹190.13 Cr₹6.52 Cr₹1.25
FY24₹218.71 Cr₹23.63 Cr₹4.54
FY25₹252.09 Cr₹31.82 Cr₹5.97
FY26₹310.41 Cr₹32.19 Cr₹6.18

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q1 FY27Apr–Jun 2026₹88 Cr₹13 Cr₹2.50+38.4%
Q4 FY26Jan–Mar 2026Audited₹81 Cr₹6 Cr₹1.21−15.0%
Q3 FY26Oct–Dec 2025₹78 Cr₹8 Cr₹1.44–
Q2 FY26Jul–Sep 2025₹79 Cr₹9 Cr₹1.73–
Q1 FY26Apr–Jun 2025₹73 Cr₹9 Cr₹1.80–
Q4 FY25Jan–Mar 2025Audited₹65 Cr₹7 Cr₹1.42–

Source: Suraksha Diagnostic’s results filed with NSE, consolidated (the whole group). Net profit is the share of Suraksha Diagnostic’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onMarch 2026September 2025March 2025
Fixed assets₹229 Cr₹169 Cr₹157 Cr
Investments₹0₹0₹1 Cr
Inventories₹8 Cr₹8 Cr₹8 Cr
Owed by customers₹23 Cr₹14 Cr₹14 Cr
Cash and equivalents₹3 Cr₹2 Cr₹2 Cr
Total assets₹448 Cr₹380 Cr₹334 Cr
Borrowings₹2 Cr₹3 Cr₹6 Cr
Total liabilities₹205 Cr₹151 Cr₹123 Cr
Shareholders’ equity₹245 Cr₹230 Cr₹211 Cr

Source: Suraksha Diagnostic’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About Suraksha Diagnostic

Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men's and women's health, senior citizens, diabetes care, fever, full-body checkups, and at-home packages. The company was founded in 1992 and is based in Kolkata, India.

Industry
Diagnostics & Research
Based in
Kolkata
Employees
1,600

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Suraksha Diagnostic in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Re 0.50 Per Share

    Dividend · ex-date 15 September 2026

Source: NSE. Latest first.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.